AI Article Synopsis

  • Thyrotoxicosis is when thyroid hormone levels are too high, affecting the whole body, and can significantly impact the heart through various mechanisms.
  • A rare case of thyrotoxic cardiomyopathy (TCM) was reported in a 37-year-old woman, characterized by heart failure with preserved ejection fraction and mainly affecting her atria.
  • The patient was diagnosed through tests showing high NT-proBNP levels and thyroid dysfunction, and she was successfully treated by a team of specialists using anti-thyroid medications and follow-up care.

Article Abstract

Thyrotoxicosis is a clinical condition characterized by inappropriately elevated thyroid hormone levels in the bloodstream, leading to systemic effects on the body. In fact, the thyrotoxic state has tight regulatory control over the cardiovascular system through genomic and non-genomic mechanisms. This study highlights a rare presentation of thyrotoxic cardiomyopathy (TCM), which, to the best of our knowledge, is one of the very few case reports involving heart failure with preserved ejection fraction (HFpEF) and only atrial involvement, compared to the previous literature. A 37-year-old female presented to the outpatient clinic with abdominal distention and neglected signs and symptoms consistent with thyrotoxicosis for a year. Investigations revealed high N-terminal pro-b-type natriuretic peptide (NT-proBNP) levels of 1788 pg/mL. Cardiac MRI and trans-thoracic echocardiogram (TTE) revealed bilateral atrial dilatation, a left ventricular ejection fraction (LVEF) of 60%, and diastolic dysfunction. Additionally, severe free-flowing tricuspid and mitral valve regurgitation were observed, with no evidence of pericardial effusion or ventricular abnormalities. Therefore, a diagnosis of TCM was suspected and eventually confirmed by excluding other differential diagnoses. Besides a diffuse goiter on ultrasonography, the thyroid panel test revealed low thyroid-stimulating hormone (TSH) levels of <0.01 mIU/L, a free thyroxine T4 of >100 pmol/L, and positive anti-thyroid peroxidase (TPO) and TSH receptor antibodies. Accordingly, a team of endocrinologists, cardiologists, and internists managed the patient with anti-thyroid medications alongside symptomatic treatment. A few days later, she was discharged in good condition, and a follow-up visit was arranged with the endocrinology and cardiology clinics. It is crucial to maintain a high level of suspicion to detect and treat TCM promptly, and a multidisciplinary approach should ideally be employed. This is not only important for the prevention of but also reversing potentially life-threatening cardiovascular complications.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10817802PMC
http://dx.doi.org/10.7759/cureus.51172DOI Listing

Publication Analysis

Top Keywords

thyrotoxic cardiomyopathy
8
ejection fraction
8
cardiomyopathy unveiled
4
unveiled insights
4
insights compelling
4
compelling case
4
case report
4
report thyrotoxicosis
4
thyrotoxicosis clinical
4
clinical condition
4

Similar Publications

Article Synopsis
  • Hyperthyroidism significantly affects the cardiovascular system, leading to conditions like thyrotoxic cardiomyopathy, which can cause heart failure.
  • A study analyzed 30,889 patients to find that the overall prevalence of heart failure in those with hyperthyroidism is 8%.
  • Key risk factors for developing heart failure in these patients include atrial fibrillation, chronic kidney disease, anemia, hypertension, and a history of stroke or coronary artery disease.
View Article and Find Full Text PDF

Acute viral myocarditis and hyperthyroidism can present with acute coronary syndrome. However, the link between hyperthyroidism and myocarditis has hardly been explored apart from a small collection of published case reports. We report a case where a patient presents with severe chest pain and was found to have concomitant severe coronary vasospasm and acute myocarditis and was diagnosed with Graves' disease.

View Article and Find Full Text PDF

Thyrotoxic periodic paralysis (TPP) and thyrotoxic cardiomyopathy (TCMP) are potentially lethal complications of thyrotoxicosis that require emergent recognition and management to attenuate significant morbidity and mortality. We present the case of a 23-year-old Asian male with no prior medical history who developed TPP with coincident TCMP, which was successfully managed with antithyroid and heart failure therapies. The clinician should be aware of the diagnosis and treatment of these 2 life-threatening conditions in a hyperthyroid state.

View Article and Find Full Text PDF
Article Synopsis
  • Thyrotoxic cardiomyopathy is a serious complication from thyrotoxicosis that can lead to acute heart failure, highlighting the need for early diagnosis and management.* -
  • A patient presented with symptoms of dyspnea and acute heart failure, leading to a diagnosis of thyrotoxic cardiomyopathy and subsequent treatment with diuretics and antiarrhythmics.* -
  • Post-treatment, the patient's heart function improved significantly, showcasing the potential for recovery and the importance of timely intervention in similar cases.*
View Article and Find Full Text PDF

Thyroid storm and heart failure represent formidable challenges in clinical practice. Their coexistence, however, poses an even greater threat to the patient's well-being. To facilitate early recognition and appropriate management, an understanding of the complex interplay between these two conditions is crucial.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!